文献速递淋巴瘤造血干细胞移植与细胞治疗

晚期B细胞肿瘤合并乙型肝炎病毒感染患者接受嵌合抗原受体(CAR)T细胞治疗的安全性与疗效

Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection.
PubMed 文献 · Leukemia · 2020-06-27

研究纳入70例接受CAR-T细胞治疗的晚期B细胞肿瘤患者,其中12例为慢性HBV感染(HBsAg阳性),29例为已消退的HBV感染(HBsAg阴性且抗-HBc阳性),并与29例无HBV感染者比较。慢性HBV感染中2例、已消退HBV感染中1例出现HBV再激活,无HBV相关肝炎发作;三组缓解率及细胞因子释放综合征(CRS)和神经毒性的发生率或严重程度均无显著差异。数据提示慢性和已消退的HBV感染不影响CAR-T细胞治疗的安全性和疗效。

要点

  • 慢性HBV感染中2例、已消退HBV感染中1例出现HBV再激活,无HBV相关肝炎发作。
  • 三组对CAR-T细胞治疗的缓解率无显著差异。
  • 三组CRS和神经毒性的发生率或严重程度无显著差异。

核心结论

  • 数据提示慢性和已消退的HBV感染不影响CAR-T细胞治疗的安全性和疗效。

研究设计与样本

  • 研究70例接受CAR-T细胞治疗的晚期B细胞肿瘤患者,其中12例为慢性HBV感染(HBsAg阳性),29例为已消退HBV感染(HBsAg阴性且抗-HBc阳性),与29例无HBV感染者比较。

主要发现

  • 慢性HBV感染中2例、已消退HBV感染中1例出现HBV再激活。
  • 无HBV相关肝炎发作。
  • 三组对CAR-T细胞治疗的缓解无显著差异。
  • 三组CRS和神经毒性的发生率或严重程度无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chimeric antigen receptor (CAR)-T-cell is a safe and effective therapy of B-cell cancers but it is unknown if this is so in persons with prior hepatitis B virus (HBV) infection. We studied 70 subjects with advanced B-cell cancers receiving CAR-T-cell therapy, 12 of whom had chronic HBV-infection (HBsAg positive) and 29 with resolved HBV-infection (HBsAg negative and anti-HBc positive). Safety and efficacy were compared with 29 subjects without HBV-infection. HBV was reactivated in 2 subjects with chronic HBV-infection and 1 with resolved HBV-infection. There was no HBV-related hepatitis flare. Responses to CAR-T-cell therapy in the three cohorts were not significantly different. There was no significant difference in the incidence or severity of cytokine release syndrome (CRS) and neurologic toxicity between the cohorts. Our data suggest that chronic and resolved HBV-infection do not affect the safety and efficacy of CAR-T-cell therapy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Wang Y, Liu Y, Tan X, et al. Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection. Leukemia. 2020. PMID: 32594100. doi:10.1038/s41375-020-0936-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。